Ordinary Soothing & Barrier Support Serum (30ml)

Targets - Barrier Support, Look of Redness

Suited to - All Skin Types

Format - Emulsion

Soothing & Barrier Support Serum is a multi-active solution targeted at reducing the look of irritated skin. It helps recover the skin barrier in 2 hours*, and provides an immediate 86%** boost in skin hydration. This helps soothe feelings of discomfort, and reduce signs of redness.

While strengthening the skin barrier, the Soothing & Barrier Support Serum also improves the look of uneven texture for a smoother appearance. Formulated with multiple vitamins, lipids, and phytotechnologies, this comprehensive serum is suitable for all skin types, including sensitive skin.

The multi-active formula contains 8 key technologies:

Vitamin B12:
Helps support skin barrier by reducing dryness and the look of redness, while also imparting the serum’s characteristic pink hue.

Gallic Acid Derivatives:
A combination of 3 activated forms of gallic acid (propyl gallate, gallyl glucoside and epigallocatechin gallyl glucoside (EGCG)) helps soothe skin discomfort and target the look of redness associated with irritants.

Bisabolol:
Helps reduce the look of skin redness

Soothing Complex:
Reduces feelings of skin tightness and discomfort from dryness.

Ceramide Complex:
Plant-derived ceramides (sphingolipids and phospholipids) provide topical delivery of key skin components.

2% Niacinamide:
Supports essential skin components that help promote hydration.

Sugar-based hydrators:
Offers skin hydration and helps support the skin barrier.

Centella Asiatica Phytotechnologies:
Isolated triterpenes; asiaticoside, madecassic acid and asiatic acid, derived from Centella Asiatica (Gotu Kola) that helps protect the skin against irritants

Testing Shows:

• Repairs and strengthens the skin barrier
• Provides an immediate 86% boost in skin hydration
• Provides hydration that lasts all day
• Reduces the look of redness
• Improves the look of uneven skin texture for a smoother appearance

*Clinical testing on 23 people after one application.
 **Clinical testing in 34 people, 2 x per day for 6 weeks.